Topical calcipotriol in the treatment of intertriginous psoriasis

British Journal of Dermatology

Volumn 135, Issue 4, 1996, Pages 647-650

  Kienbaum, S ^a   Lehmann, P ^a   Ruzicka, T ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PSORIASIS; SKIN IRRITATION; TOPICAL DRUG ADMINISTRATION;

EID: 0029799913     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb03851.x     Document Type: Article

References (14)

1. Kragballe K. Treatment of psoriasis with calcipotriol and other vitamin D analogues. J Am Acad Dermatol 1992; 27: 1001-8.
2. Kragballe K, Beck HI, Soggard H. Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind study. Br J Dermatol 1988; 119: 223-30.
3. Kragballe K, Gjertsen BT. De Hoop D et al. Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 1991; 337: 193-6.
4. Dubertret L, Wallach D, Souteyrand P et al. Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris. J Am Acad Dermatol 1992; 27: 983-8.
5. 3 and skin diseases. Arch Dermatol Res 1992; (Suppl.) 284: S30-6.
6. Bourke JF, Berth-Jones J, Iqbal SJ, Hutchinson PE. High-dose topical calcipotriol in the treatment of extensive psoriasis vulgaris. Br J Dermatol 1993; 129: 74-6.
7. Berth-Jones J. Comparison of calcipotriol ointment with betamethasone 17-valerate ointment and dithranol and investigation of the long-term safely and efficacy of calcipotriol. Acta Derm Venereol (Stockh) 1994; Suppl. 186: 46.
8. Kragballe K. Safety aspects of calcipotriol treatment. Acta Derm Venereol (Stockh) 1994; Suppl. 186: 44.
9. Scarpa C. Calcipotriol: clinical trial versus betamethasone dipropionate plus salicylic acid. Acta Derm Venereol (Stockh) 1994; Suppl. 186: 47.
10. Serup J. Calcipotriol irritation: mechanism, diagnosis and clinical implication. Acta Derm Venereol (Stockh) 1994; Suppl. 186: 42.
11. Cunliffe WJ, Berth-Jones J, Claudy A et al. Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. J Am Acad Dermatol 1992; 36: 736-43.
12. Kragballe K. Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903). Arch Dermatol 1989; 125: 1647-52.
13. 3 analogue. Contact Dermatitis 1991; 25: 139-40.
14. Bourke JF, Berth-Jones J, Elouzi H et al. The effects of up to 100 g topical calcipotriol (50μg/g) on systemic calcium homeoslasis. (abstract). J Invest Dermatol in press.